# Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

> **NCT03917940** · NA · COMPLETED · sponsor: **Damanhour University** · enrollment: 70 (actual)

## Conditions studied

- Diabetic Patients

## Interventions

- **DIETARY_SUPPLEMENT:** Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT03917940
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-31
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03917940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03917940, "Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03917940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*